AI Maternal Diagnostics Innovator joins WoHX
Boston, MA -- October 8: Women's HealthX is pleased to welcome UltrasoundAI as a Silver Sponsor for this year's event in Boston.
As highlighted in recent industry data, electronic fetal monitoring and maternal risk assessments have seen limited structural innovation over the past few decades.
The ability to accurately predict and manage high-acuity maternal events remains a critical operational challenge for health systems and payers alike.
UltrasoundAI is actively changing this paradigm by developing an advanced artificial intelligence platform designed to predict delivery timing and assess preterm birth risks with high accuracy using standard ultrasound imaging.
By operating seamlessly within existing clinical workflows, UltrasoundAI's non-invasive technology helps clinicians move out of the "diagnostic gray area" and make more informed, timely decisions for mothers and neonates without adding burdensome administrative steps.
"The company's vision aligns closely with the clinical innovation themes being explored at Women's HealthX. Throughout the event, leaders from health systems and payer organizations will discuss how modernizing frontline maternal diagnostics is essential to reducing high-acuity claims, preventing unnecessary NICU admissions, and delivering safer care at scale."
Achieving better maternal outcomes requires more than just clinical willingness; it requires giving providers the right predictive tools exactly when they need them.
We are delighted to welcome UltrasoundAI to the Women's HealthX community and look forward to showcasing their work this December.
Women’s HealthX 2026 | From Rhetoric to Results
Encore Boston Harbor | December 3-4 2026
Bypass abstract market rhetoric to evaluate real-world health economics, regulatory compliance mandates, and care delivery systems. Join the region's foremost health plan medical directors, hospital COOs, biopharma innovators, and enterprise benefits buyers anchoring our 2026 tracks.
